You are viewing: India Biosensors Market analysis
Part of: Biosensors Market (Global)

The India Biosensors Market was valued at $463.6 Million in 2025 and projected to reach to $779.5 Million by 2030, representing a compound annual growth rate of 11.0%. India's biosensors market is poised for accelerated growth driven by increasing healthcare expenditure, rising prevalence of chronic and infectious diseases, and expanding diagnostic infrastructure across urban and rural regions.

India Biosensors Market Trends and Insights

  • The region is experiencing accelerated adoption of biosensor technologies driven by rising healthcare investments, increasing prevalence of chronic diseases, and expanding diagnostic infrastructure across emerging economies.
  • Rest Of Asia Pacific is projected to reach USD 779.5 million by 2030, reflecting a compound annual growth rate of 11.0%, outpacing global market expansion. The biosensors market in Rest Of Asia Pacific is characterized by growing demand for point-of-care testing, wearable health monitoring devices, and rapid diagnostic solutions.
  • Rest Of Asia Pacific's market growth is supported by improving healthcare accessibility, government initiatives promoting digital health, and rising consumer awareness of preventive healthcare.
  • Key applications include glucose monitoring, infectious disease detection, and environmental sensing, with Rest Of Asia Pacific emerging as a critical hub for biosensor innovation and manufacturing. Rest Of Asia Pacific's competitive landscape features both established medical device manufacturers and emerging local players capitalizing on regional demand.
  • The region's growth trajectory reflects favorable demographic trends, increasing healthcare expenditure, and technological advancement in sensor miniaturization and integration..

Key Market Statistics

  • CAGR (2025-2030) 11.0% CAGR
  • Market Size, 2025 ~USD 463.6 Million
  • Forecast, 2030 ~USD 779.5 Million
  • Country India

India Biosensors Market Overview

Market Size & Growth :

India's biosensors market is valued at USD 463.6 million in 2025, with a robust 11% CAGR projected through 2030, reaching USD 779.5 million. This growth rate outpaces the global average of 9.5%, positioning India as a high-growth market within Asia Pacific.

Healthcare Infrastructure Expansion :

Rising government investments in diagnostic infrastructure and healthcare accessibility across tier-2 and tier-3 cities are driving biosensor adoption. Initiatives like Ayushman Bharat and digital health programs are accelerating demand for point-of-care testing solutions.

Chronic Disease Prevalence :

India's growing burden of diabetes, cardiovascular diseases, and infectious diseases is fueling demand for continuous monitoring biosensors. The rising middle-class population with increased health awareness is creating significant market opportunities for wearable and portable biosensor devices.

Manufacturing & Innovation Hub :

India is emerging as a manufacturing and R&D hub for biosensor technologies, supported by favorable government policies, skilled workforce, and cost-competitive production. Local startups and established medical device companies are driving innovation in glucose monitoring, pathogen detection, and biomarker sensing.

India Biosensors Market Dynamics

  • Government initiatives promoting digital health and point-of-care diagnostics are creating favorable conditions for biosensor adoption among healthcare providers and consumers. The market is expected to benefit from growing smartphone penetration enabling connected biosensor devices, rising medical tourism, and increasing collaboration between Indian companies and global biosensor manufacturers.
  • With a 11% CAGR through 2030, India represents a critical growth engine for the Asia Pacific biosensors market, attracting significant investment from both domestic and international players..

Related Ecosystem

Sensors And Control

Top Technologies
  • Sensors
  • Image Sensors
  • Temperature Sensors
  • Pressure Sensors
  • Flow Sensors
Top Companies
  • BAUMER ELECTRIC AG
  • HONEYWELL INTERNATIONAL INC.
  • Stmicroelectronics
  • Lenovo
  • Texas Instruments Incorporated

    Smart Home

    Top Technologies
    • Sensors
    • Pressure Sensors
    • Temperature Sensors
    • Actuators
    • Face Recognition
    Top Companies
    • HONEYWELL INTERNATIONAL INC.
    • SCHNEIDER ELECTRIC SE
    • Siemens ag
    • Samsung
    • ABB India Limited

      Key Takeaways

      • Rest Of Asia Pacific biosensors market is valued at USD 463.6 million in 2025 and expected to grow to USD 779.5 million by 2030 at an 11.0% CAGR.
      • Rest Of Asia Pacific demonstrates stronger growth momentum compared to the global biosensors market, driven by emerging healthcare infrastructure and rising disease prevalence.
      • Point-of-care testing and wearable biosensor devices are primary growth drivers in Rest Of Asia Pacific, supported by increasing consumer health awareness.
      • Rest Of Asia Pacific's market expansion is underpinned by government healthcare initiatives, improving diagnostic accessibility, and growing medical device manufacturing capabilities.

      Biosensors Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SENSOR PATCHES (Type)
      Forecast Period 2025–2030
      Growth Rate CAGR of 9.5% from 2025 to 2030
      Largest Segment EMBEDDED DEVICES (Type)
      Market Size Base Year (Billions) ~USD 34.54 (2025)
      Revenue Forecast (Billions) ~USD 54.37 (2030)
      Segments Covered Type, Product, Application, Technology

      India Biosensors Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Type

      • Blood Gas & Electrolyte Detection
      • Bodywear
      • Cardiac Marker Detection
      • Cholesterol Testing
      • Coagulation Monitoring
      • Embedded Devices
      • Eyewear
      • Footwear
      • Glucose Monitoring
      • Infectious Disease Detection
      • Neckwear
      • Other Wearable Biosensors
      • Pregnancy Testing
      • Sensor Patches
      • Tumor/Cancer Marker Detection
      • Urinalysis Testing
      • Wristwear

      By Product

      • Non-Wearable Biosensors
      • Wearable Biosensors

      By Application

      • Biodefense
      • Environmental Monitoring
      • Food & Beverage
      • Food & Beverages
      • Home Diagnostic
      • Home Diagnostics
      • Poc
      • Research Lab
      • Research Labs

      By Technology

      • Electrochemical
      • Nanomechanical
      • Optical
      • Piezoelectric
      • Thermal

      Target Audience

      • Medical Device Manufacturers : Evaluate India as a manufacturing hub and market opportunity. Understand local demand drivers, competitive positioning, and expansion strategies for biosensor product lines in a high-growth emerging market.
      • Healthcare Providers & Diagnostics Labs : Identify emerging biosensor technologies and suppliers to enhance diagnostic capabilities. Assess market trends in point-of-care testing and continuous monitoring solutions relevant to India's healthcare infrastructure.
      • Investment & Private Equity Firms : Evaluate investment opportunities in India's biosensors market with detailed growth projections, market dynamics, and competitive landscape. Identify acquisition targets and portfolio companies with high growth potential.
      • Government & Healthcare Policy Makers : Understand market trends and technology adoption patterns to inform healthcare policy, diagnostic infrastructure planning, and digital health initiatives aligned with India's healthcare modernization goals.
      • Startups & Entrepreneurs : Assess market opportunity, identify unmet needs, and understand competitive dynamics to develop biosensor solutions tailored to India's healthcare challenges, affordability requirements, and regulatory landscape.

      Key Companies in the India Biosensors Market

      CompanyHQOwnershipStrongest segments
      TSI INCChinaPublic CompanyTsingtao Beer (core and premium variants),Laoshan Beer,Hans Beer and other regional beers,
      X-FABGermanyPublic CompanyAnalog/Mixed-Signal Foundry (incl. automotive, industrial, consumer),MEMS and Sensor Platforms,Power (SiC, GaN, and related) and Silicon Photonics,
      LENOVOChinaPublic CompanySmall form factor / desktop PCs as signage players,Embedded / dedicated media players and thin clients,Tablets and smart devices as kiosks / POS displays,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and bioproduction solutions),Life Sciences (genomics, analytical instruments, and research tools),Diagnostics (clinical instruments, consumables, and software),
      ABBOTT LABORATORIESUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Instruments and Systems,Life Science Reagents and Consumables,
      DUPONTUnited StatesPublic CompanyHealthcare & Water Technologies,Protective Materials and Medical Packaging (TYVEK),Construction Solutions (TYVEK house wrap, STYROFOAM, CORIAN),
      BIOSENSORS INTERNATIONAL GROUP, LTD.SingaporePrivate CompanyInterventional Cardiology (DES, BMS, balloons, catheters),Critical Care (pressure transducers, CVCs, PA catheters, pacing, embolectomy),Cardiac Diagnostic (imaging and clinical applications),
      DEXCOM, INC.United StatesPublic CompanyDexcom G7 and G7 15 Day,Dexcom G6,Dexcom ONE+ and value-focused CGM,
      MASIMOUnited StatesPrivate CompanySET and Rainbow SET pulse oximetry (including sensors and OEM),Brain function and hemodynamic monitoring,Hospital automation and connectivity (Patient SafetyNet, Iris, iSirona, Replica, UniView),
      UNIVERSAL BIOSENSORSAustraliaPublic CompanyPT/INR coagulation strips and Xprecia devices,Sentia wine testing products,Laboratory and coagulation testing services,

      TSI INC

      TSI Inc is a publicly traded company founded in 1903 and headquartered in China, employing 29,257 people. The company operates as a significant industrial enterprise with a long-established presence in its market.

      X-FAB

      X-FAB is a publicly traded semiconductor manufacturer founded in 1992 and headquartered in Germany, employing 4,300 people. The company specializes in analog and mixed-signal semiconductor fabrication services.

      LENOVO

      Lenovo is a publicly traded technology company founded in 1984 and based in China, operating as a major global manufacturer of computing devices and IT solutions.

      DANAHER CORPORATION

      Danaher Corporation is a publicly traded American conglomerate founded in 1969, employing 59,000 people across diversified business segments including life sciences, diagnostics, and environmental solutions.

      ABBOTT LABORATORIES

      Abbott Laboratories is a publicly traded pharmaceutical and healthcare company founded in 1888 and headquartered in the United States, employing 115,000 people globally. The company develops and manufactures pharmaceuticals, diagnostics, nutritional products, and medical devices.

      MEDTRONIC

      Medtronic is a publicly traded medical technology company founded in 1949 and headquartered in Ireland, employing 95,000 people. The company develops and manufactures medical devices and therapies across multiple healthcare specialties.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a publicly traded company founded in 1952 and based in the United States, employing 7,450 people. The company manufactures and distributes life science research products and clinical diagnostics solutions.

      DUPONT

      DuPont is a publicly traded chemical and materials company founded in 2015 and headquartered in the United States, employing 15,000 people. The company produces specialty chemicals, advanced materials, and industrial solutions.

      BIOSENSORS INTERNATIONAL GROUP, LTD.

      Biosensors International Group, Ltd. is a private medical device company founded in 1990 and based in Singapore, employing 312 people. The company specializes in the development and manufacture of interventional cardiology devices.

      DEXCOM, INC.

      Dexcom, Inc. is a publicly traded medical technology company founded in 1999 and based in the United States, employing 11,050 people. The company specializes in continuous glucose monitoring systems for diabetes management.

      MASIMO

      Masimo is a privately held medical technology company founded in 1989 and based in the United States, employing 2,200 people. The company develops and manufactures noninvasive monitoring technologies and sensors.

      UNIVERSAL BIOSENSORS

      Universal Biosensors is a publicly traded diagnostics company founded in 2001 and based in Australia, employing 76 people. The company develops and manufactures rapid diagnostic test devices.

      Reasons to Buy this Report

      • Market Size & Forecast Data : Access precise market valuation for India at USD 463.6M (2025) and USD 779.5M (2030) with detailed CAGR analysis. Understand India's outperformance versus global 9.5% growth rate to identify high-potential investment opportunities.
      • Competitive Landscape Intelligence : Gain insights into local and international players operating in India's biosensors market, including manufacturing capabilities, R&D investments, and strategic partnerships. Identify market gaps and competitive positioning opportunities.
      • Segment & Application Analysis : Detailed breakdown of biosensor types (glucose monitoring, pathogen detection, biomarker sensing) and end-user segments (hospitals, diagnostic labs, home care) specific to India's healthcare ecosystem and consumer behavior.
      • Growth Driver Identification : Comprehensive analysis of India-specific growth catalysts including government healthcare initiatives, chronic disease prevalence, infrastructure expansion, and digital health adoption. Understand regulatory environment and reimbursement landscape.
      • Strategic Market Entry Guidance : Actionable recommendations for market entry, localization strategies, distribution channels, and partnership opportunities tailored to India's unique market dynamics, regulatory requirements, and consumer preferences.

      Frequently asked questions

      What is the market size of biosensors in Rest Of Asia Pacific in 2025?

      Rest Of Asia Pacific's biosensors market is valued at USD 463.6 million in 2025, representing a significant portion of the Asia Pacific region's overall biosensor demand.

      What is the projected market size for Rest Of Asia Pacific biosensors by 2030?

      Rest Of Asia Pacific's biosensors market is projected to reach USD 779.5 million by 2030, reflecting sustained growth and increasing market penetration.

      What is the CAGR for the biosensors market in Rest Of Asia Pacific?

      Rest Of Asia Pacific's biosensors market is expected to grow at a compound annual growth rate of 11.0% from 2025 to 2030.

      What are the primary drivers of biosensor market growth in Rest Of Asia Pacific?

      Rest Of Asia Pacific's biosensor market growth is driven by rising healthcare investments, increasing chronic disease prevalence, expanding diagnostic infrastructure, and growing adoption of wearable health monitoring devices.

      Which biosensor applications are most prominent in Rest Of Asia Pacific?

      Rest Of Asia Pacific shows strong demand for glucose monitoring biosensors, infectious disease detection devices, point-of-care testing solutions, and environmental sensing applications.

      RESEARCH METHODOLOGY

      The study involved major activities in estimating the current size of the biosensors market. Exhaustive secondary research was done to collect information on biosensors. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the biosensor.

      Secondary Research

      Various secondary sources were referred to in the secondary research process to identify and collect information relevant to this study. Secondary sources included annual reports, press releases, and investor presentations of companies; white papers, certified publications, and articles from recognized authors; directories; and databases. Secondary research was mainly carried out to obtain critical information about the industry’s supply chain, value chain, the pool of key players, and market classification and segmentation according to industry trends, geographic markets, and key developments from both market- and technology-oriented perspectives. Secondary sources included corporate filings (such as annual reports, investor presentations, and financial statements); trade, business, and professional associations; white papers; IoT technologies journals and certified publications; articles by recognized authors; gold- and silver-standard websites; directories; and databases. Data was also collected from secondary sources, such as the Semiconductor Industry Association, Global Semiconductor Alliance, and Taiwan Semiconductor Industry Association.

      Secondary research was mainly used to obtain critical information about the industry's supply chain and value chain, the total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments from both the market and technology-oriented perspectives. Secondary data has been gathered and analyzed to determine the overall market size, which has also been validated by primary research.

      Primary Research

      Extensive primary research was conducted after understanding and analyzing the current scenario of the biosensors market through secondary research. Primary interviews were held with key opinion leaders from the demand and supply sides in four key regions: North America, Europe, Asia Pacific, and the rest of the world. Nearly 25% of the primary interviews were held with the demand side and 75% with the supply side. The primary data was gathered primarily through telephonic interviews, which were 80% of the total primary interviews. Surveys and e-mails were also utilized to gather data.

      Biosensors Market
 Size, and Share

      Note: Three tiers of companies are defined based on their total revenue as of 2024; tier 1: revenue more than or equal to USD 500 million, tier 2: revenue between USD 100 million and USD 500 million, and tier 3: revenue less than or equal to USD 100 million. Other designations include sales and marketing executives, researchers, and members of various biosensor organizations.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      In this report, both the top-down and bottom-up approaches were implemented to estimate and validate the size of the biosensors market and various other dependent submarkets. Secondary research identified key players in this market, and their market shares in the respective regions were determined through primary and secondary research.

      This entire research methodology included the study of annual and financial reports of top companies, as well as interviews with experts (such as CEOs, VPs, directors, and marketing executives) for key insights (both quantitative and qualitative). All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report. The figures below show the overall market size estimation process employed for this study.

      Bottom-Up Approach

      • Key players in the biosensors market were identified through secondary research, and their global market share was determined through primary and secondary research.
      • The research methodology included a study of annual and quarterly financial reports, regulatory filings of major market players (public), and interviews with industry experts for detailed market insights.
      • All biosensor penetration rates, percentage shares, splits, and breakdowns for the biosensors market were determined using secondary sources and verified through primary sources.
      • All key macroindicators influencing the revenue growth of market segments and subsegments were considered, examined in detail, validated through primary research, and analyzed to produce accurate quantitative and qualitative data.
      • The market data gathered was consolidated, enhanced with detailed inputs, analyzed, and presented in this report.

      Top-Down Approach

      • Focusing initially on the top-line investments and expenditures made in the biosensor ecosystem, splitting the key market areas into component, type, product, technology, and region, and listing key developments
      • Identifying all leading players and end users in the biosensors market based on product, type, technology, and application through secondary research and fully verifying them through a brief discussion with industry experts
      • Analyzing revenues, product mix, geographic presence, and key applications served by all identified players to estimate and arrive at percentage splits for all key segments
      • Discussing splits with industry experts to validate the information and identify key growth pockets across all key segments
      • Breaking down the total market based on verified splits and key growth pockets across all segments

      Biosensors Market : Top-Down and Bottom-Up Approach

      Biosensors Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the overall size of the biosensors market from the estimation process explained above, the market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed (wherever applicable) to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. The biosensors market size was validated using both top-down and bottom-up approaches.

      Market Definition

      Biosensors are semiconductor devices designed to detect biological responses using transducers that convert these responses into electrical signals. They achieve this by combining a biological recognition element (bioreceptor) with a physicochemical transducer. The bioreceptor specifically interacts with a particular biological analyte. The transducer then converts this interaction into a measurable signal, such as an electrical current, optical change, mass change, or thermal signal, which relates to the analyte’s concentration. Common bioreceptors include enzymes, antibodies, nucleic acids, cells, or microorganisms. They are used as analytical tools to deliver qualitative or quantitative results in detecting protein or nucleic acid targets.

      Key Stakeholders

      • Semiconductor Industry Association
      • Global Semiconductor Alliance
      • European Semiconductor Industry Association
      • Taiwan Semiconductor Industry Association
      • International Diabetes Federation (IDF)
      • American Diabetes Association (ADA)
      • National Biodefense Analysis and Countermeasures Center (NBACC).
      • IEEE
      • Educational Institutions Research/White Papers (Published by Communication Organizations)
      • Investor Presentations and Annual Reports of Key Market Players

      Report Objectives

      • To define, describe, and forecast the biosensors market, by type, product, technology, application, and region, in terms of value
      • To define, describe, and forecast the global biosensors market by product, in terms of volume
      • To forecast the sizes of various segments with respect to the four major regions: North America, Europe, Asia Pacific, and Rest of the World (RoW)
      • To provide a detailed analysis of the biosensors supply chain
      • To strategically analyze the micromarkets with respect to individual growth trends and prospects, and their contributions to the total market
      • To analyze competitive developments, such as expansions, agreements, partnerships, acquisitions, product developments, and research & development (R&D), in the biosensors market
      • To analyze the opportunities for market players and provide details of the market's competitive landscape
      • To benchmark the market players using the proprietary company evaluation matrix framework, which analyzes the market players on various parameters within the broad categories of business strategy excellence and strength of product portfolios
      • To strategically profile the key players and comprehensively analyze their market positions in terms of ranking and core competencies, along with a detailed competitive landscape of the market
      • To analyze the supply chain, ecosystem, trend/disruptions impacting customer business, technologies, trade & patent scenario, key conferences & events, regulations, and conduct Porter’s five force analysis

      Available customizations:

      With the market data given, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

      Company Information

      • Detailed analysis and profiling of additional market players (up to 7)

      Get the Full Biosensors Market Report

      Full forecast, segment splits, and company analysis for all Biosensors Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status